Literature DB >> 30923799

Increase in Infant Measles Deaths During a Nationwide Measles Outbreak-Mongolia, 2015-2016.

Christopher T Lee1, Jose E Hagan2, Baigalmaa Jantsansengee3, Oyun-Erdene Tumurbaatar3, Samdan Altanchimeg4, Buyanjargal Yadamsuren4, Sodbayar Demberelsuren5, Chinbayar Tserendorj4, Oyungerel Munkhtogoo4, Darmaa Badarch4, Nyamaa Gunregjav4, Bolortuya Baatarkhuu6, Chimedsuren Ochir7, LaShondra Berman8, Raydel Anderson8, Minal K Patel2, Christopher J Gregory9, James L Goodson2.   

Abstract

BACKGROUND: Surveillance data from a large measles outbreak in Mongolia suggested increased case fatality ratio (CFR) in the second of 2 waves. To confirm the increase in CFR and identify risk factors for measles death, we enhanced mortality ascertainment and conducted a case-control study among infants hospitalized for measles.
METHODS: We linked national vital records with surveillance data of clinically or laboratory-confirmed infant (aged <12 months) measles cases with rash onset during March-September 2015 (wave 1) and October 2015-June 2016 (wave 2). We abstracted medical charts of 95 fatal cases and 273 nonfatal cases hospitalized for measles, matched by age and sex. We calculated adjusted matched odds ratios (amORs) and 95% confidence intervals (CIs) for risk factors.
RESULTS: Infant measles deaths increased from 3 among 2224 cases (CFR: 0.13%) in wave 1 to 113 among 4884 cases (CFR: 2.31%) in wave 2 (P < .001). Inpatient admission, 7-21 days before measles rash onset, for pneumonia or influenza (amOR: 4.5; CI, 2.6-8.0), but not other diagnoses, was significantly associated with death. DISCUSSION: Measles infection among children hospitalized with respiratory infections likely increased deaths due to measles during wave 2. Preventing measles virus nosocomial transmission likely decreases measles mortality. Published by Oxford University Press for the Infectious Diseases Society of America 2019.

Entities:  

Keywords:  Mongolia; case fatality; health care-associated infection; measles; mortality

Mesh:

Year:  2019        PMID: 30923799      PMCID: PMC7034305          DOI: 10.1093/infdis/jiz140

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Case-fatality rate during a measles outbreak in eastern Niger in 2003.

Authors:  Robin Nandy; Thomas Handzel; Maman Zaneidou; José Biey; Rene Z Coddy; Robert Perry; Peter Strebel; Lisa Cairns
Journal:  Clin Infect Dis       Date:  2005-12-19       Impact factor: 9.079

2.  Measles vaccines: WHO position paper – April 2017.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2017-04-28

Review 3.  Measles.

Authors:  Paul A Rota; William J Moss; Makoto Takeda; Rik L de Swart; Kimberly M Thompson; James L Goodson
Journal:  Nat Rev Dis Primers       Date:  2016-07-14       Impact factor: 52.329

4.  Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens.

Authors:  Kimberly B Hummel; Luis Lowe; William J Bellini; Paul A Rota
Journal:  J Virol Methods       Date:  2005-11-07       Impact factor: 2.014

5.  Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality.

Authors:  Michael J Mina; C Jessica E Metcalf; Rik L de Swart; A D M E Osterhaus; Bryan T Grenfell
Journal:  Science       Date:  2015-05-07       Impact factor: 47.728

6.  Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy.

Authors:  Moe H Kyaw; Peter Christie; Stuart C Clarke; John D Mooney; Syed Ahmed; Ian G Jones; Harry Campbell
Journal:  Clin Infect Dis       Date:  2003-10-17       Impact factor: 9.079

7.  Adenovirus Type 7 Pneumonia in Children Who Died from Measles-Associated Pneumonia, Hanoi, Vietnam, 2014.

Authors:  Le Thanh Hai; Hoang Ngoc Thach; Ta Anh Tuan; Dao Huu Nam; Tran Minh Dien; Yuko Sato; Toshio Kumasaka; Tadaki Suzuki; Nozomu Hanaoka; Tsuguto Fujimoto; Harutaka Katano; Hideki Hasegawa; Shoji Kawachi; Noriko Nakajima
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

8.  Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals.

Authors:  Li Liu; Shefali Oza; Dan Hogan; Yue Chu; Jamie Perin; Jun Zhu; Joy E Lawn; Simon Cousens; Colin Mathers; Robert E Black
Journal:  Lancet       Date:  2016-11-11       Impact factor: 79.321

9.  Epidemiological characteristics and trends of a Nationwide measles outbreak in Mongolia, 2015-2016.

Authors:  Oyunchimeg Orsoo; Yu Mon Saw; Enkhbold Sereenen; Buyanjargal Yadamsuren; Ariunsanaa Byambaa; Tetsuyoshi Kariya; Eiko Yamamoto; Nobuyuki Hamajima
Journal:  BMC Public Health       Date:  2019-02-15       Impact factor: 3.295

10.  Use of a Diagonal Approach to Health System Strengthening and Measles Elimination after a Large Nationwide Outbreak in Mongolia.

Authors:  José E Hagan; Ashley Greiner; Ulzii-Orshikh Luvsansharav; Jason Lake; Christopher Lee; Roberta Pastore; Yoshihiro Takashima; Amarzaya Sarankhuu; Sodbayar Demberelsuren; Rachel Smith; Benjamin Park; James L Goodson
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883

View more
  8 in total

1.  Risk factors for measles deaths among children during a Nationwide measles outbreak - Romania, 2016-2018.

Authors:  Morgane Donadel; Aurora Stanescu; Adriana Pistol; Brock Stewart; Cassandra Butu; Dragan Jankovic; Bogdan Paunescu; Laura Zimmerman
Journal:  BMC Infect Dis       Date:  2021-03-19       Impact factor: 3.090

2.  Measles outbreak in the Philippines: epidemiological and clinical characteristics of hospitalized children, 2016-2019.

Authors:  Fleurette M Domai; Kristal An Agrupis; Su Myat Han; Ana Ria Sayo; Janine S Ramirez; Raphael Nepomuceno; Shuichi Suzuki; Annavi Marie G Villanueva; Eumelia P Salva; Jose Benito Villarama; Koya Ariyoshi; Kim Mulholland; Luigi Palla; Kensuke Takahashi; Chris Smith; Edna Miranda
Journal:  Lancet Reg Health West Pac       Date:  2021-12-15

3.  Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study.

Authors:  Claire von Mollendorf; Mukhchuluun Ulziibayar; Bradford D Gessner; Lien Anh Ha Do; Cattram D Nguyen; Rohini Beavon; Bujinlkham Suuri; Dashtseren Luvsantseren; Dorj Narangerel; Adam Jenney; Eileen M Dunne; Catherine Satzke; Badarchiin Darmaa; Tuya Mungun; E Kim Mulholland
Journal:  BMC Public Health       Date:  2021-09-23       Impact factor: 3.295

4.  Measles outbreak in Western Uganda: a case-control study.

Authors:  Abel Wilson Walekhwa; Moses Ntaro; Peter Chris Kawungezi; Chiara Achangwa; Rabbison Muhindo; Emmanuel Baguma; Michael Matte; Richard Migisha; Raquel Reyes; Peyton Thompson; Ross M Boyce; Edgar M Mulogo
Journal:  BMC Infect Dis       Date:  2021-06-22       Impact factor: 3.090

5.  Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Thomas R Frieden; Christopher T Lee
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

6.  An evaluation of the clinical features of measles virus infection for diagnosis in children within a limited resources setting.

Authors:  Dominicus Husada; Dwiyanti Puspitasari; Leny Kartina; Parwati Setiono Basuki
Journal:  BMC Pediatr       Date:  2020-01-06       Impact factor: 2.125

7.  Exploring the Possible Cause of the Dramatic Increase in Measles Mortality During the 2015-2016 Mongolian Outbreak.

Authors:  Lien Anh Ha Do; Naranzul Tsedenbal; Claire von Mollendorf; Tuya Mungun; Darmaa Bardach; Kim Mulholland
Journal:  J Infect Dis       Date:  2021-10-13       Impact factor: 5.226

8.  Measles susceptibility in maternal-infant dyads-Bamako, Mali.

Authors:  Meredith G Dixon; Milagritos D Tapia; Kathleen Wannemuehler; Richard Luce; Mark Papania; Samba Sow; Myron M Levine; Marcela F Pasetti
Journal:  Vaccine       Date:  2022-01-31       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.